InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert
28 avr. 2022 07h30 HE
|
InMed Pharmaceuticals Inc.
Expands library of proprietary cannabinoid analogs for pharma R&DResearch collaboration initiated to screen analogs for therapeutic uses VANCOUVER, British Columbia and SOUTH SAN FRANCISCO,...
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
21 avr. 2022 16h52 HE
|
AREV Life Sciences Global Corp.
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announced today its initial...
ECGI Approaching Key Strategic Milestones in the Cannabinoid Marketplace
29 mars 2022 08h30 HE
|
ECGI Holdings, Inc.
LOS ANGELES, March 29, 2022 (GLOBE NEWSWIRE) -- via InvestorWire - ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company...
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer
28 mars 2022 08h30 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the...
RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol
23 mars 2022 08h00 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
CBD Pharmaceuticals (a subsidiary of Yuluka Health SAS) Signs Major Long-Term Seed Supply Agreements with Leading European Wholesalers to Start in the 2022 Calendar Year
22 mars 2022 16h51 HE
|
Yuluka Health Inc.
CALI, Colombia, March 22, 2022 (GLOBE NEWSWIRE) -- Yuluka Health SAS is pleased to announce the final stage of completion of its licensing and infrastructure upgrades of its subsidiary CBD...
InMed to Present at the 34th Annual Roth Conference
08 mars 2022 07h30 HE
|
InMed Pharmaceuticals Inc.
Vancouver, BC, March 08, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and...
UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer
24 févr. 2022 16h09 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on...
Isracann Signs LOI to Acquire Natural Health Medicine Developer
23 févr. 2022 08h30 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on...
Introducing Herve x MoonWLKR Le Mirage Moon Rocks
22 févr. 2022 08h00 HE
|
Hervé
Luxury Edibles Brand Hervé Announces Launch of ‘Le Mirage’ Hard Candy Products with MoonWLKR Le Mirage will be the foundation of MoonWLKR’s new line of sublingual fast-acting products. LAS...